Your browser doesn't support javascript.
loading
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience.
Besle, Sylvain; Schultz, Emilien; Hollebecque, Antoine; Varga, Andreea; Baldini, Capucine; Martin, Patricia; Postel-Vinay, Sophie; Bahleda, Rastislav; Gazzah, Anas; Michot, Jean-Marie; Marabelle, Aurélien; Angevin, Eric; Armand, Jean-Pierre; Ribrag, Vincent; Soria, Jean-Charles; Massard, Christophe.
Afiliação
  • Besle S; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France; Aix Marseille Univ, INSERM, IRD, SESSTIM, 232 Bd Ste Marguerite BP 156 13273 Marseille Cedex 9 France. Electronic address: sylvain.besle@gustaveroussy.fr.
  • Schultz E; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France; Aix Marseille Univ, INSERM, IRD, SESSTIM, 232 Bd Ste Marguerite BP 156 13273 Marseille Cedex 9 France.
  • Hollebecque A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Varga A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Baldini C; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Martin P; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Postel-Vinay S; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Bahleda R; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Gazzah A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Michot JM; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Marabelle A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Angevin E; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Armand JP; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Ribrag V; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Soria JC; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
  • Massard C; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.
Eur J Cancer ; 98: 17-22, 2018 07.
Article em En | MEDLINE | ID: mdl-29859337
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Médicos de Família / Encaminhamento e Consulta / Ensaios Clínicos como Assunto / Seleção de Pacientes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Médicos de Família / Encaminhamento e Consulta / Ensaios Clínicos como Assunto / Seleção de Pacientes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article